WestPark Capital analyst Curtis Shauger initiated coverage on Alphabet (NASDAQ:GOOG) on Tuesday with a Buy rating and a price ...

We recently published a list of Jim Cramer Says I’m With Trump & Discusses These 12 Stocks. In this article, we are going to ...

As STAT’s Katie Palmer reports in a new story, the lack of standards for collection of this information will make it more ...

In a quarter marred by tariff uncertainty, US government spending cuts and the threat of recession, it is fears about a ...

Alphabet's diverse, high-margin growth engines like AI, Cloud & YouTube drive strong revenue growth. Click here to read my ...

Isomorphic Labs says it is advancing drug design programs across multiple therapeutic areas and drug modalities. These ...

Isomorphic Labs, the AI drug-discovery platform that was spun out of Google's DeepMind in 2021, has raised external capital ...

The Magnificent Seven declined on Monday, capping off the worst month and quarter on record for the group of big tech stocks ...

AlphaFold 3, the improved version of the model used by Isomorphic Labs’ drug design engine, debuted last May. It can predict ...

The drug discovery company, which has partnerships with Eli Lilly and Novartis, is developing AI models to design drugs and ...

The London-based business – which launched in 2021 – will use the funds to further its research, expand its team and continue ...

Deployment of AI is accelerating exponentially, and the nascent industry requires unprecedented investment to grow. We spoke ...